Skip to content
Spastic Paraparesis
- Clinical picture
- Walking aids / wheelchair
- Disuse atrophy
- Increased tone, usually in the lower limbs first
- Hyperreflexia
- Pyramidal weakness below the level of the lesion
- Sensation usually intact
- Some forms of hereditary spastic paraplegia may involve mild dorsal column loss
- Causes
- Human T cell lymphotropic virus-1 (HTLV1, tropical spastic paraparesis)
- Retrovirus which infects CD4 T cells
- Transmission: vertical, sexual, contaminated blood products
- Often in Africa, South America and southern Japan
- Also causes adult T cell leukaemia / lymphoma
- Lifetime risk of haematological or neurological events in carriers: 0.25 – 3%
- Usual onset 40 – 50, more common in women
- Onset usually asymmetric and gradual, with gait and urinary disturbance
- May have brisk upper limb reflexes
- Hereditary spastic paraplegia
- Almost 50 gene loci
- De novo mutations are frequent
- May be inherited in autosomal dominant, autosomal recessive or X-linked pattern
- Autosomal dominant is most common
- Phenotype and penetrance is variable – determining family history may be difficult
- Usually presents in the fourth decade (range of first till seventh decade)
- Spastic paraparesis, usually of the lower limbs
- 30% have dorsal column involvement
- 30% have neurogenic bladder
- Primary lateral sclerosis (see Motor Neurone Disease)
- Investigation
- Peripheral blood film
- Atypical T lymphocytes with convoluted nuclei – “flower cells” (HTLV1)
- HTLV1 antibodies in CSF and serum
- Genetic testing for hereditary spastic paraparesis (most common is spastic paraplegia gene 4)
- Management
- Multidisciplinary team approach
- HTLV
- Transient improvement with corticosteroids
- Combivir (lamivudine + zidovudine) may decrease viral load, no evidence for effect on neurological function
Page load link
Leave A Comment